Bacterial Conjunctivitis
📧 Sign up to get email alerts when something new happens for Bacterial Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine [Phase 4]
Phase 4 trial comparing topical hypochlorous acid (Avenova) to povidone-iodine (Betadine) for bacterial eye infections is currently suspende…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis [Phase 2]
Phase 2 trial results evaluating IVIEW-1201 for acute bacterial conjunctivitis have been reported, detailing the treatment's efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects [Phase 1]
A Phase 1 trial comparing the safety and tolerability of PRO-231 versus VIGAMOXI on the ocular surface in healthy subjects has completed, wi…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of vancomycin ophthalmic ointment for moderate to severe bacterial conjunctivitis; results …
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults [Phase 2]
Phase 2 clinical trial evaluating RD03/2016 for the treatment of bacterial conjunctivitis in adults has completed, assessing its effects and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. [Phase 3]
Phase 3 trial evaluating efficacy of ophthalmic pazufloxacin 0.6% vs gatifloxacin 0.3% for bacterial conjunctivitis; study terminated with p…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo [Phase 3]
Phase 3 trial comparing SHP640 to PVP-Iodine and placebo for bacterial conjunctivitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) [Phase 2]
Phase 2 trial comparing PRO-157 (pazufloxacin) to moxifloxacin and gatifloxacin for bacterial conjunctivitis has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: AL-15469A for the Treatment of Bacterial Conjunctivitis [Phase 3]
The update indicates that a Phase 3 trial evaluating AL-15469A for bacterial conjunctivitis has completed. No trial results are disclosed in…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis [Phase 2]
Phase 2 clinical trial evaluating Auriclosene for bacterial conjunctivitis has completed, reporting on its efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients [Phase 3]
A Phase 3 trial compared safety and efficacy of VIGAMOX (moxifloxacin ophthalmic solution 0.5%) versus Ofloxacin ophthalmic solution 0.3% in…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis [Phase 3]
Phase 3 trial evaluating besifloxacin ophthalmic suspension 0.6% for bacterial conjunctivitis was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis [Phase 3]
A Phase 3 trial comparing besifloxacin ophthalmic suspension with gatifloxacin ophthalmic solution in neonates with bacterial conjunctivitis…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle [Phase 3]
A Phase 3 safety study comparing Besivance (besifloxacin ophthalmic suspension) 0.6% to vehicle in bacterial conjunctivitis, with results po…
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis [Phase 2, Phase 3]
Phase 2/3 clinical trial update reports efficacy results for besifloxacin ophthalmic suspension in the treatment of bacterial conjunctivitis…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Systemic Pharmacokinetics of BOL-303224-A [Phase 1]
Phase 1 trial update reports systemic pharmacokinetics data for BOL-303224-A in bacterial conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of gatifloxacin ophthalmic solution for bacterial conjunctivitis, with results pos…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis [Phase 3]
Phase 3 trial evaluating gatifloxacin for safety and efficacy in bacterial conjunctivitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) [Phase 3]
A Phase 3 trial evaluating AzaSite (azithromycin ophthalmic solution) versus vehicle for bacterial conjunctivitis has completed and results …
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004) [Phase 3]
Phase 3 trial comparing AzaSite (azithromycin ophthalmic solution) to tobramycin for bacterial conjunctivitis assessed clinical and microbia…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis [Phase 4]
This is a Phase 4 clinical trial evaluating gatifloxacin for bacterial conjunctivitis. The study has completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis [Phase 3]
Phase 3 clinical trial update for moxifloxacin ophthalmic solution in bacterial conjunctivitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy of Maxinom and Maxitrol in reducing signs and symptoms of acute bacterial conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the effectiveness of TOBRACORT versus TOBRADEX for reducing the signs and symptoms of acute bacterial conj…
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment [Phase 4]
Phase 4 clinical trial update examining progression of bacterial conjunctivitis symptoms during antibiotic treatment.